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Objective: To determine the frequency, clinical profile and outcome of
patients with Williams syndrome and neonatal coarctation.
Patients and Results: Among 135 reviewed patients less than 3months
of age who underwent aortic coarctation repair in our institution between
January 1996 and June 2007, Williams syndrome was found in 3 cases
(2,2%). They presented with congestive heart failure and absent femoral
pulses, the diagnostic being confirmed by echocardiography. One case had
an associated small ventricular septal defect. The 3 patients were operated at
a mean age and weight of 51.6±32.7days and 3.5±0.6kg, respectively. All
had resection of the coarctation segment with end-to-end anastomosis,
through left thoracotomy in 2 cases, and sternotomy under cardiopulmonary
bypass with large patch enlargement of the aortic arch and ventricular septal
defect closure in one. The diagnosis of Williams syndrome was confirmed
postoperatively by FISH analysis. All patients remained hypertensive and
presented with recoarctation 2, 2.3, and 14.3months after initial repair. Tran-
scatheter balloon dilation was attempted with failure to proceed in one and
partial success in 2 cases. All had redo surgery at 0.6, 1.2 and 10.9 years
after initial repair with patch enlargement of the aorta in two cases and an
extra-anatomic bypass in the third, with good results and discontinuation of
antihypertensive treatment.
Conclusion: Williams syndrome may present as neonatal coarctation and is
characterized by more complex repair and recurrent aortic obstruction. Balloon
dilation seems disappointing to treat successfully these recoarctations. Reoper-
ations are often necessary with patch enlargement and/or exclusion of the
stenotic aortic segment.
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The rate of supraventricular tachycardias (SVT) depends on the atrioven-
tricular (AV) nodal conduction. Classicaly the maximal rate of AV nodal con-
duction decreases with the age. The purpose of the study was to look for the
rate of induced SVT according to the age of the patient.
Methods: Electrophysiological study was performed in 1003 patients
without WPW in sinus rhythm, but presenting with SVT; 68 were aged from
5 to 20 years (mean 15±3),102 from 21 to 30 (25±3), 134 from 31 to 40
(37±3), 188 from 41 to 50 (46±3), 187 from 51 to 60 (55±3), 155 from 61 to
70 (66±3), 155 aged from 71 to 80 (75±3), and 51 aged more than 80 years.
SVT was induced by programmed atrial.
Results: The rate in SVT was similar in teenagers and adults until 50 years
(mean 196±37 b/min) (respectively 197±29 b/min before 21 years, 217±44 b/
min from 21 to 30 years, 193±40 b/min from 31 to 40 years and 192±33 b/
min from 41 to 50 years) (NS). The rate in SVT was similar from 51 to 80
years (mean 172±33 b/min), but was significantly slower than before 51 years
(p < 0.01); the rates were respectively 178±36 from 51 to 60 years, 167±34 b/
min from 61 to 70 years, 172±26 b/min from 71 to 80 years (NS). The rate
was significantly slower in patients older than 80 years compared to all ranges
of age (138±32 b/min). Patients with syncope associated to SVT had a higher
rate of SVT (199±41 b/min) than patients without syncope (182.5±36.5 b/min)
(p<0003) However, the incidence of syncope was similar in teenagers and
adults < 51 years (13 % in all ranges of age), decreased between 51 and 70
years (5 and 8 %) and increased from 71 to 93 years (15 and 16 %).
Conclusions: The rate of SVT seems depend on the autonomic nervous
tone. The rate was relatively high in teenagers but also in all adults < 51 years.
It is slower from 51 until 80 years but it is more markedly slower after 80
years. Similar correlations were found with the incidence of syncope associ-
ated with SVT.
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Purpose: We sought to evaluate the clinical usefulness of cardiac MRI for
making the definitive diagnosis of acute myocarditis in children.
Material and Methods: Twenty-three children (age 12 years, range 1 -15
years) were hospitalized in our institution for suspected acute myocarditis. The
following examinations were performed : ECG, cardiac enzymes including
troponin, chest x-ray, transthoracic echocardiography, and cardiac MRI. Car-
diac MRI were performed with a 1.5T machine using the following sequences
: SSFP, T2-weighted black blood, perfusion, and myocardial delayed enhance-
ment. Diagnosis of acute myocarditis was based on MRI: normal perfusion but
presence of subepicardial hypersignal on the T2-weighted and SSFP sequences
associated with an enhancement late after peripheral injection of gadolinium.
Results: The following diagnosis were found: acute myocarditis (n=12),
primitive dilated myocardiopathy (n=8), normal heart (n=3). Among the 12
cases of acute myocarditis on MRI, 9 patients presented with recent symptoms
(< 7 days), increased troponin enzymes (0.21-54 μg/ml), and ECG abnormal-
ities. There were focal abnormalities in left ventricle contraction on echocar-
diography in 5 patients. The 3 other patients with abnormal MRI presented
with symptoms that dated more than 7 days. In these cases, tropinin enzymes,
ECG and transthoracic echocardiography were normal.
Biological examinations and coronary CT angiography were normal in the
11 patients (8 patients with a dilated cardiomyopathy and 3 patients with
normal heart) who did not presented with myocarditis on MRI.
Conclusion: Focal subepicardial hypersignal on cardiac MRI associated
increased troponin enzymes allowed to make the definitive diagnosis of acute
myocarditis in children who presented with symptoms that dated less than 7 days.
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Background: CHARGE syndrome (MIM 214800) consists of a combina-
tion of congenital malformations including Coloboma, Heart defects, Atresia
of choanae, Retardation of growth and developmental delay, Genital anomalies
and Ear anomalies. Diagnosis criteria have been recently refined and several
other features have been described such as semi-circular canals and cranial
nerve anomalies. A CHD7 gene mutation is found in 60 % of patients with a
clinical diagnosis of CHARGE syndrome. Although frequently found, cardio-
vascular malformations (CVM) are not specific.
Methods: In our series, 85% of CHARGE patients with CHD7 mutation
have a CVM. We report on the spectrum of CVM in 65 CHD7 mutated
patients (including 15 fetuses). All patients were precisely assessed for their
cardiac phenotype by echocardiography, CT scan or pathology.
Results: Conotruncal malformations (n=16), aortic arch anomalies (n=10)
and atrioventricular septal defects (n=15), were the most frequent CVM. A
rare association of atrioventricular septal defect and transposition of the great
arteries was described in one patient. Despite the small number of mutated
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cases, our data suggest that hypomorphic mutations (missense, splice sites) are
less frequently associated to a heart defect than nonsense and frameshift muta-
tions.
Conclusions: Although being a minor criteria because of lack of speci-
ficity, CVM proved to be very frequent in CHD7 mutated CHARGE patients.
The neural crest cells origin hypothesis of the CVM cannot account for all
observed defects. Cardiac progenitor cells of the second heart field might be
implicated in embryological mechanisms leading to CVM in CHARGE syn-
drome.
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Background: Therapeutic options at time of worsening remain unclear in
children who do worse but remain in functional class III while being on com-
bined oral therapy with endothelin receptor antagonists and PDE-5 inhibitors.
Objective: To evaluate the use of a subcutaneous prostanoid as an ad-on
therapy in pediatric PAH.
Patients and methods: Five children with PAH (median age 4 years,
range 1.5–9 y) received subcutaneous treprostinil at time of worsening PAH.
Two had idiopathic PAH, one being familial. Three patients had PAH asso-
ciated with but not caused by congenital heart defect. All had severe PAH
and were non responsive to inhaled nitric oxide. They were all on combined
oral therapy with bosentan and sildenafil. Indication to add treprostinil was
clinical deterioration with right ventricular failure in 4 patients and switch
from IV epoprostenol in one. Treprostinil was initiated at a fixed dose of
1.25 ng/kg/min and then daily increased by 1.25 ng/kg/min to reach an
average dose of 20 ng/kg/min.
Results: Local tolerance was good with tailored management of site injec-
tion. No serious adverse events was noted during the median 6 months follow-
up. All patients were clinically improved with significant increase in 6MWT
distance in the 3 oldest children and change from WHO functional class III to
class II. Echocardiography showed an improved right ventricular function,
increased pulmonary flow with increased acceleration time.
Conclusion: Subcutaneous treprostinil can be a valuable alternative in
pediatric PAH patients already receiving combined oral therapy. It may help
to avoid complications of central lines and to improve quality of life.
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Background: 3D echocardiography is a validated method to evaluate left
ventricular (LV) volumes and function. Because of its peculiar morphology,
the right ventricle (RV) volumes can not be calculated with 3D softwares used
for LV quantification. Recently, new 3D software adapted for RV morphology
was introduced.
Aim: To evaluate the feasibility of 3D RV analysis in a pediatric popula-
tion and to compare RV 3D data with LV 3D measurements.
Methods: Fifty-one pediatric patients (median age 10 years) with normal
cardiac anatomy and function were included. 3D transthoracic echocardio-
graphy was performed with the X4-2 or X7-2 matrix probe (ie33, Philips Med-
ical Systems, Andover, MA). Three LV and RV full volume sweeps were
acquired from apical views. The volumes were analysed with the LV and the
dedicated RV analysis softwares (TomTec Imaging Systems, Munich, Ger-
many).
Results: Measurements feasibility was 100% for LV and 95% for RV. The
RV had higher volumes but smaller ejection fraction compared to LV (RV
end-diastolic volume 59 ml, LV end-diastolic volume 46 ml; RV end-systolic
volume 29 ml, LV end-systolic volume 17 ml; RV ejection fraction 53%, LV
ejection fraction 66%).The stroke volumes of the two ventricles were highly
related with a mean difference of 1+/-2 ml (r= 0,95). The intra- and interob-
server variabilities ranged from RV 3D volumes (0.4%-2%, and 0.2%-4%).
Conclusion: 3D echocardiography using dedicated software is a feasible
and adequate method for RV volume quantification in a normal pediatric pop-
ulation. Further studies are needed to validate the accuracy of the method to
calculate enlarged RV volumes in patients with congenital heart diseases. 
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Background: Despite successful surgical correction, morbidity of patients
with coarctation of the aorta(CoAo) is high. The increased large arteries stiff-
ness may be related to their impaired prognosis.
Purpose: The aim of the study is to asses the relationship between aortic
stiffness parameters (2D echo), aortic wall velocities (tissue Doppler imaging,
TDI) and carotid stiffness parameters (e-tracking) in pts. with repaired CoAo.
Methods: Study group consisted of 23 pts. with repaired CoAo (mean age
28,6 ± 9,9 yrs) and 20 matched healthy subjects.
Aortic elasticity was assessed using M-mode evaluation of aortic diame-
ters, then calculating accepted indexes: aortic strain (Ao Strain), distensibility
(Ao Dis), stiffness index (Ao SI). 
Systolic maximum expansion velocity (SW) of aortic wall was assesed
using TDI.E-tracking determined parameters were: pulse wave velocity
(PWV), stiffness index (β), elastic modulus (Ep), arterial compliance (AC).
Results: When correlating (table) the parameters derived from the 3
methods, statistical significant association (*) was obtained for Ao M-mode
3D reconstruction of the right ventricle
